Literature DB >> 28302518

Mutations in PIK3R1 can lead to APDS2, SHORT syndrome or a combination of the two.

M Bravo García-Morato1, S García-Miñaúr2, J Molina Garicano3, F Santos Simarro2, L Del Pino Molina4, E López-Granados4, A Ferreira Cerdán4, R Rodríguez Pena4.   

Abstract

Mutations in PIK3R1 gene have been associated to two different conditions: a primary immunodeficiency, called APDS2, of recent description and SHORT syndrome. 47 patients with APDS2 have been reported to date, only one of them sharing both PIK3R1-related phenotypes. Here we describe two more patients affected by APDS2 and SHORT syndrome, which highlights that this association may not be so infrequent. We recommend that patients with mutations in PIK3R1 gene should be assessed by both clinical immunologists and clinical geneticists.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Genetic diagnosis; Primary immunodeficiencies; SHORT syndrome

Mesh:

Substances:

Year:  2017        PMID: 28302518     DOI: 10.1016/j.clim.2017.03.004

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  15 in total

Review 1.  Immune Dysregulation and Disease Pathogenesis due to Activating Mutations in PIK3CD-the Goldilocks' Effect.

Authors:  Stuart G Tangye; Julia Bier; Anthony Lau; Tina Nguyen; Gulbu Uzel; Elissa K Deenick
Journal:  J Clin Immunol       Date:  2019-03-25       Impact factor: 8.317

Review 2.  Herpesviruses in the Activated Phosphatidylinositol-3-Kinase-δ Syndrome.

Authors:  Jeffrey I Cohen
Journal:  Front Immunol       Date:  2018-02-23       Impact factor: 7.561

Review 3.  Phosphoinositide-3-Kinase Signaling in Human Natural Killer Cells: New Insights from Primary Immunodeficiency.

Authors:  Emily M Mace
Journal:  Front Immunol       Date:  2018-03-07       Impact factor: 7.561

4.  STAT3 gain-of-function mutation in a patient with pulmonary Mycobacterium abscessus infection.

Authors:  Miguel S Gonzalez-Mancera; Britt Johnson; Mehdi Mirsaeidi
Journal:  Respir Med Case Rep       Date:  2020-06-12

Review 5.  Bacille Calmette-Guerin Complications in Newly Described Primary Immunodeficiency Diseases: 2010-2017.

Authors:  Cristiane de Jesus Nunes-Santos; Sergio D Rosenzweig
Journal:  Front Immunol       Date:  2018-06-22       Impact factor: 7.561

Review 6.  Class-Switch Recombination (CSR)/Hyper-IgM (HIGM) Syndromes and Phosphoinositide 3-Kinase (PI3K) Defects.

Authors:  Rekha D Jhamnani; Cristiane J Nunes-Santos; Jenna Bergerson; Sergio D Rosenzweig
Journal:  Front Immunol       Date:  2018-09-26       Impact factor: 7.561

Review 7.  Epstein-Barr Virus Susceptibility in Activated PI3Kδ Syndrome (APDS) Immunodeficiency.

Authors:  Jean-Marie Carpier; Carrie L Lucas
Journal:  Front Immunol       Date:  2018-01-16       Impact factor: 7.561

Review 8.  Molecular Mechanisms of Human Disease Mediated by Oncogenic and Primary Immunodeficiency Mutations in Class IA Phosphoinositide 3-Kinases.

Authors:  Gillian L Dornan; John E Burke
Journal:  Front Immunol       Date:  2018-03-19       Impact factor: 7.561

Review 9.  Respiratory Manifestations of the Activated Phosphoinositide 3-Kinase Delta Syndrome.

Authors:  Alison M Condliffe; Anita Chandra
Journal:  Front Immunol       Date:  2018-03-05       Impact factor: 7.561

10.  Successful Sirolimus Treatment for Korean Patients with Activated Phosphoinositide 3-kinase δ Syndrome 1: the First Case Series in Korea.

Authors:  Ji Man Kang; Su Kyung Kim; Dongsub Kim; Sae Rom Choi; Yeon Jung Lim; Soon Ki Kim; Byung Kiu Park; Weon Seo Park; Eun Suk Kang; Young Hyeh Ko; Yon Ho Choe; Ji Won Lee; Yae Jean Kim
Journal:  Yonsei Med J       Date:  2020-06       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.